Access the full text.
Sign up today, get DeepDyve free for 14 days.
MP Mehta, P Rodrigus, CH Terhaard, A Rao, J Suh, W Roa, L Souhami, A Bezjak, M Leibenhaut, R Komaki, C Schultz, R Timmerman, W Curran, J Smith, SC Phan, RA Miller, MF Renschler (2003)
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastasesJ Clin Oncol, 21
BS Skeie, PO Enger, JC Ganz, GO Skeie, E Parr, S Hatteland, B Ystevik, JI Heggdal, PH Pedersen (2013)
Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth controlWorld Neurosurg, 79
I Corre, M Guillonneau, F Paris (2013)
Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicityInt J Mol Sci, 14
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ST Chao, RJ Weil, J Suh, A Bhatt, AW Jensen, PD Brown, HA Shih, J Kirkpatrick, LE Gaspar, JB Fiveash, V Chiang, JP Knisely, CM Sperduto, N Lin, M Mehta (2012)
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesJ Clin Oncol, 30
JS Loeffler, FG Barker, PH Chapman (1999)
Role of radiosurgery in the management of central nervous system metastasesCancer Chemother Pharmacol, 43
P Kaur, A Asea (2012)
Radiation-induced effects and the immune system in cancerFront Oncol, 2
Y Lee, SL Auh, Y Wang, B Burnette, Y Wang, Y Meng, M Beckett, R Sharma, R Chin, T Tu, RR Weichselbaum, YX Fu (2009)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentBlood, 114
PD Brown, K Jaeckle, KV Ballman, E Farace, JH Cerhan, SK Anderson, XW Carrero, FG Barker, R Deming, SH Burri, C Menard, C Chung, VW Stieber, BE Pollock, E Galanis, JC Buckner, AL Asher (2016)
Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trialJAMA, 316
M Yamamoto, T Kawabe, Y Sato, Y Higuchi, T Nariai, S Watanabe, H Kasuya (2014)
Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2–9 versus 10 or more tumorsJ Neurosurg, 121
M Al-Zabin, WO Ullrich, A Brawanski, MA Proescholdt (2010)
Recurrent brain metastases from lung cancer: the impact of reoperationActa Neurochir, 152
H Aoyama, H Shirato, M Tago, K Nakagawa, T Toyoda, K Hatano, M Kenjyo, N Oya, S Hirota, H Shioura, E Kunieda, T Inomata, K Hayakawa, N Katoh, G Kobashi (2006)
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trialJAMA, 295
G Rodrigues, J Zindler, A Warner, F Lagerwaard (2013)
Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion controlOncologist, 18
DA Schomas, JC Roeske, RL MacDonald, PJ Sweeney, N Mehta, AJ Mundt (2005)
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brainAm J Clin Oncol, 28
T Shuto, S Inomori, H Fujino, H Nagano (2006)
Gamma knife surgery for metastatic brain tumors from renal cell carcinomaJ Neurosurg, 105
PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, S Fox, JH Suh, D Roberge, V Kavadi, SM Bentzen, MP Mehta, D Watkins-Bruner (2013)
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialNeuro Oncol, 15
EL Chang, U Selek, SJ Hassenbusch, MH Maor, PK Allen, A Mahajan, R Sawaya, SY Woo (2005)
Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgeryNeurosurgery, 56
V Gondi, SL Pugh, WA Tome, C Caine, B Corn, A Kanner, H Rowley, V Kundapur, A DeNittis, JN Greenspoon, AA Konski, GS Bauman, S Shah, W Shi, M Wendland, L Kachnic, MP Mehta (2014)
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trialJ Clin Oncol, 32
R Kolesnick, Z Fuks (2003)
Radiation and ceramide-induced apoptosisOncogene, 22
PD Brown, KV Ballman, J Cerhan, SK Anderson, XW Carrero, AC Whitton, J Greenspoon, IF Parney, NN Laack, JB Ashman, JP Bahary, CG Hadjipanayis, JJ Urbanic, FG Barker, II Farace, D Khuntia, C Giannini, JC Buckner, E Galanis, D Roberge (2016)
N107C/CEC.3: a phase III trial of post-operative stereotactic radiosurgery (SRS) compared with whole brain radiotherapy (wbrt) for resected metastatic brain diseaseInt J Radiat Oncol Biol Phys, 96
M Kocher, R Soffietti, U Abacioglu, S Villa, F Fauchon, BG Baumert, L Fariselli, T Tzuk-Shina, RD Kortmann, C Carrie, M Ben Hassel, M Kouri, E Valeinis, D Berge, S Collette, L Collette, RP Mueller (2011)
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 studyJ Clin Oncol, 29
M Garcia-Barros, F Paris, C Cordon-Cardo, D Lyden, S Rafii, A Haimovitz-Friedman, Z Fuks, R Kolesnick (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosisScience, 300
C Heisterkamp, T Haatanen, SE Schild, D Rades (2010)
Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancerStrahlenther Onkol, 186
E Shaw, C Scott, L Souhami, R Dinapoli, R Kline, J Loeffler, N Farnan (2000)
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90- 05Int J Radiat Oncol Biol Phys, 47
EL Chang, JS Wefel, KR Hess, PK Allen, FF Lang, DG Kornguth, RB Arbuckle, JM Swint, AS Shiu, MH Maor, CA Meyers (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialLancet Oncol, 10
A Muacevic, FW Kreth, A Mack, JC Tonn, B Wowra (2004)
Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinomaMinim Invasive Neurosurg, 47
C Nieder, W Berberich, K Schnabel (1997)
Tumor-related prognostic factors for remission of brain metastases after radiotherapyInt J Radiat Oncol Biol Phys, 39
M Garcia-Barros, D Lacorazza, H Petrie, A Haimovitz-Friedman, C Cardon-Cardo, S Nimer, Z Fuks, R Kolesnick (2004)
Host acid sphingomyelinase regulates microvascular function not tumor immunityCancer Res, 64
L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, WG McKenna, R Byhardt (1997)
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trialsInt J Radiat Oncol Biol Phys, 37
JH Suh, B Stea, A Nabid, JJ Kresl, A Fortin, JP Mercier, N Senzer, EL Chang, AP Boyd, PJ Cagnoni, E Shaw (2006)
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastasesJ Clin Oncol, 24
B Wowra, M Siebels, A Muacevic, FW Kreth, A Mack, A Hofstetter (2002)
Repeated gamma knife surgery for multiple brain metastases from renal cell carcinomaJ Neurosurg, 97
RM Auchter, JP Lamond, E Alexander, JM Buatti, R Chappell, WA Friedman, TJ Kinsella, AB Levin, WR Noyes, CJ Schultz, JS Loeffler, MP Mehta (1996)
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasisInt J Radiat Oncol Biol Phys, 35
Brain metastases are the most common intracranial tumors in adults, accounting for more than 50% of all such cases. The approach to and management of brain metastases have evolved significantly in recent years due to several reasons. These include advances in neurosurgical and radiotherapeutic techniques, improved systemic therapy options offering better systemic and intracranial disease control and prolongation of survival as a result of these improvements, making side-effects of proposed therapies (e.g. neurocognitive decline from whole brain radiotherapy) an important consideration. In this article, we review the the primary therapeutic approaches to the management of brain metastases, namely, surgery, stereotactic radiosurgery, and whole brain radiation therapy and the primary factors dictating choice.
Clinical & Experimental Metastasis – Springer Journals
Published: Nov 14, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.